m+Medelevator.RU
← Поиск публикаций
The Journal of veterinary medical science · 2026

The Na+/Ca2+ exchanger: molecular structure, functional regulation, and mode-selective modulation.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ono Naoshige, Nishiyama Kazuhiro, Azuma Yasu-Taka

Аннотация

The Na+/Ca2+ exchanger (NCX) is a key regulator of intracellular Ca2+ homeostasis, mediating bidirectional ion transport in response to electrochemical gradients. NCX plays essential roles in diverse physiological processes, including cardiac contraction, neuronal signaling, and hormone secretion, while its dysregulation is implicated in a wide range of pathophysiological conditions such as heart failure, ischemia, and neurodegenerative diseases. Recent advances in structural biology, particularly cryo-electron microscopy, have provided detailed insights into the molecular architecture of eukaryotic NCX, revealing the mechanisms underlying ion transport, regulation, and inactivation. These studies have highlighted the functional importance of conserved structural elements, including the α1- and α2-repeats and cytosolic regulatory domains, in governing exchanger activity. In parallel, pharmacological studies have identified a variety of NCX modulators with distinct mode and isoform selectivity. While classical inhibitors predominantly target the reverse mode, emerging compounds-including highly selective inhibitors and novel activators-demonstrate diverse mechanisms of action, often involving allosteric modulation rather than direct interaction with the ion-binding site. This review integrates current knowledge of NCX structure, function, and pharmacology, with a particular focus on the relationship between structural determinants and transport mode selectivity. We also discuss the challenges that have limited the clinical translation of NCX-targeting drugs and outline future perspectives for the rational design of next-generation NCX modulators.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты